Travere Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Travere Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2012 to Q3 2024.
  • Travere Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -542 %, a 877% decline year-over-year.
  • Travere Therapeutics, Inc. annual Return On Equity for 2023 was -56.7 %, a 74.1% increase from 2022.
  • Travere Therapeutics, Inc. annual Return On Equity for 2022 was -219 %, a 297% decline from 2021.
  • Travere Therapeutics, Inc. annual Return On Equity for 2021 was -55.2 %, a 13.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -542 -486 -877% Jul 1, 2024 Sep 30, 2024
Q2 2024 -102 +171 +62.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -96 +140 +59.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -56.7 +162 +74.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -55.4 +82.3 +59.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -274 -179 -190% Apr 1, 2023 Jun 30, 2023
Q1 2023 -236 -166 -236% Jan 1, 2023 Mar 31, 2023
Q4 2022 -219 -164 -297% Oct 1, 2022 Dec 31, 2022
Q3 2022 -138 -55.2 -67% Jul 1, 2022 Sep 30, 2022
Q2 2022 -94.5 -16 -20.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -70.3 +4.75 +6.33% Jan 1, 2022 Mar 31, 2022
Q4 2021 -55.2 +8.89 +13.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -82.5 -53.2 -182% Jul 1, 2021 Sep 30, 2021
Q2 2021 -78.5 -42.1 -116% Apr 1, 2021 Jun 30, 2021
Q1 2021 -75.1 -31.9 -74% Jan 1, 2021 Mar 31, 2021
Q4 2020 -64.1 -7.25 -12.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -29.3 +14.6 +33.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -36.4 +10.8 +22.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -43.2 -1.77 -4.28% Jan 1, 2020 Mar 31, 2020
Q4 2019 -56.9 -23.3 -69.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -43.9 -6.25 -16.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -47.2 -21.5 -83.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -41.4 -18.9 -84.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -33.5 -13.5 -67.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -37.6 -20.9 -124% Jul 1, 2018 Sep 30, 2018
Q2 2018 -25.7 -2.58 -11.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -22.5 +0.35 +1.53% Jan 1, 2018 Mar 31, 2018
Q4 2017 -20 -4.66 -30.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -16.8 -3.32 -24.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -23.1 -56.1 -170% Apr 1, 2017 Jun 30, 2017
Q1 2017 -22.8 -56.3 -168% Jan 1, 2017 Mar 31, 2017
Q4 2016 -15.3 -66.9 -130% Oct 1, 2016 Dec 31, 2016
Q3 2016 -13.5 -76.8 -121% Jul 1, 2016 Sep 30, 2016
Q2 2016 33 +81.3 Apr 1, 2016 Jun 30, 2016
Q1 2016 33.5 +18.9 +130% Jan 1, 2016 Mar 31, 2016
Q4 2015 51.5 -491 -90.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 63.3 -527 -89.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -48.4 -607 -109% Apr 1, 2015 Jun 30, 2015
Q1 2015 14.6 -563 -97.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 543 +207 +61.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 590 +242 +69.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 559 +87.2 +18.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 577 -441 -43.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 335 -1.53K Oct 2, 2013 Dec 31, 2013
Q3 2013 349 -8.9K -96.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 471 Apr 1, 2013 Jun 30, 2013
Q1 2013 1.02K Jan 1, 2013 Mar 31, 2013
Q4 2012 1.87K* Sep 1, 2012 Nov 30, 2012
Q3 2012 9.25K Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.